AlphaYouJB
Congress trade
Sen. John Boozman (R-AR) sold $1K-$15K of Eli Lilly and Company (LLY) stock
John Boozman, U.S. Senator (R-AR), disclosed a sale of Eli Lilly and Company (LLY) stock worth $1K-$15K in a STOCK Act filing on Dec 8, 2025.
The trade happened on Nov 21, 2025, 17 days before it was made public.
LLY has moved +11.3% since the trade date, from $1059.70 to $1179.27 (Oct 9, 2026 close).
- Traded
- Nov 21, 2025
- Disclosed
- Dec 8, 2025
- Filing delay
- 17 days
- Price since
- +11.3%
- Source
- STOCK Act disclosure
Other trades in this disclosure (13)
- SellAAXJ$1K-$15KDec 8, 2025
- SellCRM$1K-$15KDec 8, 2025
- SellEFA$1K-$15KDec 8, 2025
- SellEIPI$1K-$15KDec 8, 2025
- SellFISV$1K-$15KDec 8, 2025
- SellFTGC$1K-$15KDec 8, 2025
- SellGEM$1K-$15KDec 8, 2025
- SellIVV$1K-$15KDec 8, 2025
- SellIWM$1K-$15KDec 8, 2025
- SellRNWAX$1K-$15KDec 8, 2025
- SellTPYP$1K-$15KDec 8, 2025
- SellVEA$1K-$15KDec 8, 2025
- SellVNQI$1K-$15KDec 8, 2025
More LLY insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.